News

Results Found (504)
August 5, 2020
GemmaCert Analyzes Cannabis Potency in Minutes

GemmaCert a Yissum cannabis-tech spinout, has developed in-house testing solutions to test the active ingredients in cannabis by analyzing total THC and CBD levels throughout the entire supply chain. 

August 2, 2020
Future Meat Technologies & Savor Eat Finalists in Food Innovation Contest

Congratulations to Yissum spinouts Future Meat Technologies and SavorEat for making the finals in the FoodTech Innovation contest sponsored by Calcalist and Tnuva.

July 28, 2020
Yissum Spinouts Raise $79 million in H1 2020 Despite Coronavirus Uncertainty

Startups from The Hebrew University of Jerusalem raised $79 million in the first half of 2020. Despite the continuing global uncertainty caused by the coronavirus and ongoing lockdowns around the world, 14 Yissum spinouts raised tens of millions...

July 27, 2020
Savor Eat Raises $3M to 3D Print Customized Burgers

SavorEat announced a $3M Series A funding round from Meitav Dash following a recent raise of $1.75M in seed funding from Millennium Food Tech. Their goal is to offer personalized burgers tailor-fitted to your preferred taste.

July 23, 2020
Better Juice partners with US companies for sugar-reduction tech

Better Juice teamed up with several U.S.-based global beverage companies to commercialize its sugar-reduction technology.

July 23, 2020
Betalin to Start Human Trials

Yissum subsidiary, Betalin Therapeutics Ltd. has announced that it is ready to start human trials pending approval. It's "bio-artificial” pancreas aims to free patients of the need for insulin injections and blood sugar...

July 15, 2020
Nectin Therapeutics Raises $6M from aMoon Velocity

Nectin Therapeutics, a leading developer of next-generation immuno-oncology bio therapies, raised $6 million with the total expected to reach $15 million. The investment round was led by aMoon Velocity, the early-stage fund of VC aMoon Fund.

May 5, 2020
Hebrew U Reseachers Develop Injection to Fight Superbugs

New treatment, which allows previously topical drug to be administered intravenously, is ‘a game-changer’ in the battle against antibiotic-resistant bacteria. It could have a significant impact on the morbidity rate for pandemics such as...

March 29, 2020
HU Researchers Submit Proposals to IIA to Investigate Covid-19 Treatments

Researchers at The Hebrew University of Jerusalem as well as several Yissum start-up companies are exploring a variety of methods to combat the COVID-19 virus, through investigations into AI drug discovery, biochemical detection tools, and...

November 4, 2019
AUTM ASIA 2019 A HUGE SUCCESS WITH 190 RESEARCH INSTITUTIONS FROM OVER 30...

The largest international technology transfer conference, AUTM ASIA, took place for the first time in Israel, hosted by ITTN & Yissum,– now celebrating its 55th year.
 
See highlights from the first, second & third days! 

November 3, 2019
SHUK TECH: FOOD TECH SCIENCE AND INNOVATION AT JERUSALEM'S MACHANE YEHUDA MARKET

The Jerusalem Development Authority and Yissum hosted a night of netowrking, delicious food, craft beer, live music and informal pitches from top reseachers and entrepreneurs developing game changing new food technologies.

Featured commercially...

October 24, 2019
AI Peptide Startup Pepticom Raises $5 Million

Jerusalem-based Pepticom Ltd. has raised $5 million in a series A funding round, the company announced Thursday. Founded in 2011, Pepticom uses artificial intelligence algorithms to design peptide drug candidates based on the known structure of...